The PI3K (phosphatidylinositol-3-kinase)/Akt (protein kinase B) pathway is aberrantly activated in many types of cancer, and associated with resistance to cancer therapy and poor prognosis [1,2,3]. The gene discussed is AKT1; the disease is cancer.